Michael Cassetta
Chief Operating Officer & Chief Financial Officer
Replay available
Liquidia Corporation (NASDAQ: LQDA) Q2 2025 earnings conference call, held 2025-08-12. Replay captured from the company's public earnings webcast.

Chief Operating Officer & Chief Financial Officer
Analyst, BTIG
Chief Medical Officer
Chief Business Officer
Chief Executive Officer
General Counsel
Analyst, Needham
Analyst, Wells Fargo
Chief Commercial Officer
Analyst, LifeSide Capital
Analyst, Bank of America
Analyst
Good morning and welcome everyone to the Liquidia Corporation second quarter 2025 financial results and corporate update conference call. My name is Nadia and I will be your conference operator today. Currently all participants are in listen only mode. Following the presentation we will conduct a question and answer session. Instructions will be provided at that time for you to queue for up for questions. I would like to remind everyone that this conference call is being recorded. I will now hand the conference call over to Jason Adair, Chief Business Officer. Please go ahead, sir. Thank you, operator, and good morning, everyone. It's my pleasure to welcome you to the Liquidia Corporation second quarter 2025 financial results and corporate update call. Joining the call today are Chief Executive Officer, Dr. Roger Jeffs, Chief Operating Officer and CFO, Michael Cassetta, Chief Medical Officer, Dr. Rajiv Sagar, Chief Commercial Officer, Scott Mumaw, and General Counsel Rusty Schoenler. Before we begin, please note that today's conference call will contain forward-looking statements, including those regarding future results, unaudited and forward-looking financial information, and the company's future performance and or achievements. These statements are subject to known and unknown risks and uncertainties, which may cause actual results or performance to differ materially. For more information, please refer to the documents filed with the SEC available on our website. With that, I'd like to turn the call over to Roger for our prepared remarks. Roger? Thanks, Jason, and good morning, everyone. We are very pleased and excited to share our first commercial data for eutropia with everyone this morning. It's been a spectacular beginning. Just over 11 weeks ago, we were prou...